Table 1.
Demographic and clinical characteristics of the participants
| Characteristics | Entire cohort | p | |
|---|---|---|---|
| COVID-19 Positive (n = 328) |
COVID-19 Negative (n = 75) |
||
| Age | 57.57 ± 11.42 | 57.82 ± 11.10 | 0.501 |
| Female,n(%) | 89 (27.1) | 24 (32.0) | 0.482 |
| BMI | 25.57 ± 7.75 | 24.92 ± 3.48 | 0.479 |
| Hypertension | 173 (52.7) | 30 (40.0) | 0.062 |
| Diabetes mellitus | 96 (29.3) | 13 (17.3) | 0.036 |
| Hyperlipidemia | 115 (35.1) | 13 (17.3) | 0.005 |
| COPD | 5 (1.5) | 0 | 0.619 |
| Peripheral vascular disease | 15 (4.6) | 3 (4.0) | NA |
| Cerebrovascular events | 47 (14.3) | 11 (14.7) | NA |
| Myocardial infarction | 45 (13.7) | 12 (16.0) | 0.743 |
| Chronic heart failure | 21 (6.4) | 1 (1.3) | 0.144 |
| Creatinine | 84.94 ± 70.18 | 85.28 ± 67.47 | 0.383 |
| Ejection fraction | 58.20 (8.64) | 56.97 (9.30) | 0.277 |
| NYHA class | 0.936 | ||
| I | 111 (33.8) | 27 (36.0) | |
| II | 206 (62.8) | 45 (60.0) | |
| III | 11 (3.3) | 3 (4.0) | |
| Surgery type | 0.102 | ||
| CABG | 191(58.2) | 51(68.0) | |
| CABG + valvular surgery | 17(5.2) | 0(0) | |
| Valvular surgery | 66(20.1) | 9(12.0) | |
| Aortic dissection repair | 29(8.8) | 7(9.3) | |
| Other | 25(7.6) | 8(10.7) | |
BMI = body mass index; COPD = chronic obstructive pulmonary disease; Values are n (%) for categorical variables